Zobrazeno 1 - 3
of 3
pro vyhledávání: '"engineered immunocytokine"'
Autor:
Anje Cauwels, Sandra Van Lint, Geneviève Garcin, Jennyfer Bultinck, Franciane Paul, Sarah Gerlo, José Van der Heyden, Yann Bordat, Dominiek Catteeuw, Lode De Cauwer, Elke Rogge, Annick Verhee, Gilles Uzé, Jan Tavernier
Publikováno v:
OncoImmunology, Vol 7, Iss 3 (2018)
Despite approval for the treatment of various malignancies, clinical application of cytokines such as type I interferon (IFN) is severely impeded by their systemic toxicity. AcTakines (Activity-on-Target cytokines) are optimized immunocytokines that,
Externí odkaz:
https://doaj.org/article/fe18f4ea4f164935b446279ebe4c2ff6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cauwels A; Cytokine Receptor Laboratory, Flanders Institute of Biotechnology, VIB Medical Biotechnology Center, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Van Lint S; Cytokine Receptor Laboratory, Flanders Institute of Biotechnology, VIB Medical Biotechnology Center, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Garcin G; University Montpellier, Place Eugène Bataillon, Montpellier, France., Bultinck J; Cytokine Receptor Laboratory, Flanders Institute of Biotechnology, VIB Medical Biotechnology Center, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Present address: Oxyrane, Zwijnaarde-Gent, Belgium., Paul F; University Montpellier, Place Eugène Bataillon, Montpellier, France., Gerlo S; Cytokine Receptor Laboratory, Flanders Institute of Biotechnology, VIB Medical Biotechnology Center, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Van der Heyden J; Cytokine Receptor Laboratory, Flanders Institute of Biotechnology, VIB Medical Biotechnology Center, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Bordat Y; University Montpellier, Place Eugène Bataillon, Montpellier, France., Catteeuw D; Cytokine Receptor Laboratory, Flanders Institute of Biotechnology, VIB Medical Biotechnology Center, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., De Cauwer L; Cytokine Receptor Laboratory, Flanders Institute of Biotechnology, VIB Medical Biotechnology Center, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Present address: Argenx BVBA, Zwijnaarde-Gent, Belgium., Rogge E; Cytokine Receptor Laboratory, Flanders Institute of Biotechnology, VIB Medical Biotechnology Center, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Verhee A; Cytokine Receptor Laboratory, Flanders Institute of Biotechnology, VIB Medical Biotechnology Center, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Uzé G; University Montpellier, Place Eugène Bataillon, Montpellier, France., Tavernier J; Cytokine Receptor Laboratory, Flanders Institute of Biotechnology, VIB Medical Biotechnology Center, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2017 Nov 27; Vol. 7 (3), pp. e1398876. Date of Electronic Publication: 2017 Nov 27 (Print Publication: 2018).